Charles River Laboratories International (CRL) Other Working Capital Changes (2016 - 2026)
Charles River Laboratories International (CRL) posted Other Working Capital Changes of -$18.3 million for Q1 2018, down 546.8% on a QoQ basis from $4.1 million in Q2 2017, and down 546.8% year-over-year from $4.1 million in Q1 2017.
Analysis
Charles River Laboratories International (CRL) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Charles River Laboratories International has reported Other Working Capital Changes for 10 years, with the latest figure at -$18.3 million in Q1 2018.
- On a quarterly basis, Other Working Capital Changes fell 546.8% year-over-year to -$18.3 million in Q1 2018; TTM through Mar 2018 was -$643000.0, a 103.27% decrease from a year earlier, with the FY2016 full-year figure at $14.6 million, up 132.39% from the prior year.
- Other Working Capital Changes was -$18.3 million for Q1 2018 at Charles River Laboratories International, down from $4.1 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $43.1 million in Q3 2025, with the low at -$103.4 million in Q4 2025.
- Average Other Working Capital Changes over 5 years is $3.0 million, with a median of $10.2 million recorded in 2026.
- The sharpest annual moves came in 2014 and 2018: Other Working Capital Changes soared 1431.15% in 2014, then tumbled 546.8% in 2018.
- Over 5 years, Other Working Capital Changes stood at $13.4 million in 2014, then sank by 62.6% to $5.0 million in 2015, then surged by 147.28% to $12.4 million in 2016, then plunged by 67.01% to $4.1 million in 2017, then sank by 546.8% to -$18.3 million in 2018.
- The last three Other Working Capital Changes figures came in at -$18.3 million (Q1 2018), $4.1 million (Q2 2017), and $12.4 million (Q4 2016), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 11.81 Mn |
| Jun 27, 2026 | 11.81 Mn |
| Mar 28, 2026 | 8.52 Mn |
| Mar 28, 2026 | 8.52 Mn |
| Dec 27, 2025 | -103.42 Mn |
| Dec 27, 2025 | -103.42 Mn |
| Sep 27, 2025 | 43.07 Mn |
| Sep 27, 2025 | 43.07 Mn |
| Jun 28, 2025 | 26.26 Mn |
| Jun 28, 2025 | 26.26 Mn |
| Mar 29, 2025 | -4.05 Mn |
| Mar 29, 2025 | -4.05 Mn |
| Dec 28, 2024 | 12.76 Mn |
| Dec 28, 2024 | 12.76 Mn |
| Sep 28, 2024 | -7.42 Mn |
| Sep 28, 2024 | -7.42 Mn |
| Jun 29, 2024 | 13.64 Mn |
| Jun 29, 2024 | 13.64 Mn |
| Mar 30, 2024 | 33.02 Mn |
| Mar 30, 2024 | 33.02 Mn |